References
- Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol. 2020;1268:123–39.
- Razi S, Enayatrad M, Mohammadian-Hafshejani A, Salehiniya H, Fathali-Loy-Dizaji M, Soltani S. The epidemiology of skin cancer and its trend in Iran. Int J Prevent Med. 2015;6:64.
- Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409–13. doi:https://doi.org/10.7314/apjcp.2015.16.4.1409
- Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses’ Health Study. Int J Epidemiol. 2006;35(6):1514–21. Dec. doi:https://doi.org/10.1093/ije/dyl197
- Pfeifer GP, Besaratinia A. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci. 2012;11(1):90–7. doi:https://doi.org/10.1039/c1pp05144j
- Juzeniene A, Grigalavicius M, Baturaite Z, Moan J. Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves. Int J Hyg Environ Health. 2014;217(8):839–44. doi:https://doi.org/10.1016/j.ijheh.2014.06.002
- Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3(5):1548–54. doi:https://doi.org/10.2215/CJN.01350308
- Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58.
- Tsugane S, Inoue M. Insulin resistance and cancer: epidemiological evidence. Cancer Sci. 2010;101(5):1073–9. doi:https://doi.org/10.1111/j.1349-7006.2010.01521.x
- Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, et al. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstetr Gynecol. 2011;204(4):355.e17. doi:https://doi.org/10.1016/j.ajog.2010.11.033
- Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A, et al. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol. 2011;29(1):32–9. 1. doi:https://doi.org/10.1200/JCO.2009.26.4473
- Petridou ET, Sergentanis TN, Antonopoulos CN, Dessypris N, Matsoukis IL, Aronis K, Efremidis A, Syrigos C, Mantzoros CS. Insulin resistance: an independent risk factor for lung cancer? Metabol: Clin Exp. 2011;60(8):1100–6. Augdoi:https://doi.org/10.1016/j.metabol.2010.12.002
- Gursoy A. Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses. 2010;74(1):35–6. doi:https://doi.org/10.1016/j.mehy.2009.08.021
- Neyestani TR. Vitamin D and skin cancer: meet sunshine halfway. Bioactive dietary factors and plant extracts in dermatology. New York: Springer; 2013. p. 257–68.
- Napolitano M, Megna M, Monfrecola G. Insulin resistance and skin diseases. Scientific World J. 2015;2015:479354. doi:https://doi.org/10.1155/2015/479354
- González-Saldivar G, Rodríguez-Gutiérrez R, Ocampo-Candiani J, González-González JG, Gómez-Flores M. Skin manifestations of insulin resistance: from a biochemical stance to a clinical diagnosis and management. Dermatol Ther. 2017;7(1):37–51. doi:https://doi.org/10.1007/s13555-016-0160-3
- Hermanns-Lê T, Scheen A, Piérard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203. doi:https://doi.org/10.2165/00128071-200405030-00008
- Paolino G, Donati M, Didona D, Mercuri SR, Cantisani C. Histology of non-melanoma skin cancers: an update. Biomedicines. 2017;5(4):71.
- Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–801. doi:https://doi.org/10.1172/JCI29069
- Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, Clement N, Moes S, Colombi M, Meier JA, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538–50. doi:https://doi.org/10.1172/JCI96139
- Neagu M, Constantin C, Caruntu C, Dumitru C, Surcel M, Zurac S. Inflammation: a key process in skin tumorigenesis. Oncol Lett. 2019;17(5):4068–84. doi:https://doi.org/10.3892/ol.2018.9735
- Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007;30(8):2091–7. doi:https://doi.org/10.2337/dc07-0203
- Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest. 2008;38(7):502–9. doi:https://doi.org/10.1111/j.1365-2362.2008.01962.x
- Lupu M, Caruntu A, Caruntu C, Papagheorghe LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki M, et al. Neuroendocrine factors: the missing link in non‑melanoma skin cancer (Review). Oncol Rep. 2017;38(3):1327–40. doi:https://doi.org/10.3892/or.2017.5817
- Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Sig Transduct Target Ther. 2020;5(1):1–15. doi:https://doi.org/10.1038/s41392-020-00259-8
- Reddy P, Lent-Schochet D, Ramakrishnan N, McLaughlin M, Jialal I. Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes. Clin Chim Acta. 2019;496:35–44. doi:https://doi.org/10.1016/j.cca.2019.06.019
- Hua S. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Front Pharmacol. 2013;4:127. doi:https://doi.org/10.3389/fphar.2013.00127
- Rubin D, Claas S, Pfeuffer M, Nothnagel M, Foelsch UR, Schrezenmeir J. s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids Health Dis. 2008;7(1):32. doi:https://doi.org/10.1186/1476-511X-7-32
- Hsu L-A, Ko Y-L, Wu S, Teng M-S, Chou H-H, Chang C-J, Chang P-Y. Association of soluble intercellular adhesion molecule–1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism. 2009;58(7):983–8. doi:https://doi.org/10.1016/j.metabol.2009.02.021
- Mulhem A, Moulla Y, Klöting N, Ebert T, Tönjes A, Fasshauer M, Dietrich A, Schön MR, Stumvoll M, Richter V, et al. Circulating cell adhesion molecules in metabolically healthy obesity. Int J Obes (Lond). 2021;45(2):331–6. doi:https://doi.org/10.1038/s41366-020-00667-4
- Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol. 2019;10:1078. doi:https://doi.org/10.3389/fimmu.2019.01078
- Chen Q, Massagué J. Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clin Cancer Res. 2012;18(20):5520–5. doi:https://doi.org/10.1158/1078-0432.CCR-11-2904
- Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9(1):48. doi:https://doi.org/10.1186/1741-7015-9-48
- Rezaiian F, Nikooyeh B, Neyestani TR. Are there relationships between the VDR-FokI polymorphism and vitamin D and the insulin resistance in non-melanoma skin cancer (NMSC) patients? A protocol for case-control studies. Nutrit Food Sci Res. 2020;7(1):1–7.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. doi:https://doi.org/10.1007/BF00280883
- Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–11. doi:https://doi.org/10.2337/dc12-0336
- Li P, Wang T, Zeng C, Yang M, Li G, Han J, Wu W. Association between metabolic syndrome and prognosis of breast cancer: a meta-analysis of follow-up studies. Diabetol Metab Syndr. 2020;12(1):10. doi:https://doi.org/10.1186/s13098-019-0514-y
- Guo M, Liu T, Li P, Wang T, Zeng C, Yang M, Li G, Han J, Wu W, Zhang R, et al. Association between metabolic syndrome and breast cancer risk: an updated meta-analysis of follow-up studies. Front Oncol. 2019;9:1290. doi:https://doi.org/10.3389/fonc.2019.01290
- Barbato MT, Criado PR, Silva AKd, Averbeck E, Guerine MB, Sá NBd. Association of acanthosis nigricans and skin tags with insulin resistance. An Bras Dermatol. 2012;87(1):97–104. doi:https://doi.org/10.1590/s0365-05962012000100012
- Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169(5):1505–22. doi:https://doi.org/10.2353/ajpath.2006.051090
- Richarz N, Boada A, Carrascosa J. Angiogenesis in dermatology - insights of molecular mechanisms and latest developments. Actas Dermosifiliogr. 2017;108(6):515–23. doi:https://doi.org/10.1016/j.ad.2016.12.001
- Mackenzie KA, Miller AP, Hock BD, Gardner J, Simcock JW, Roake JA, Dachs GU, Robinson BA, Currie MJ. Angiogenesis and host immune response contribute to the aggressive character of non‐melanoma skin cancers in renal transplant recipients. Histopathology. 2011;58(6):875–85. doi:https://doi.org/10.1111/j.1365-2559.2011.03845.x
- Clark C, Rudolph J, Gerber D, Glick S, Shalita A, Lowenstein E. Dermatologic manifestation of hyperandrogenism: a retrospective chart review. Skinmed. 2014;12(2):84–8.
- Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr. 2011;3(1):1–13. doi:https://doi.org/10.1186/1758-5996-3-12
- Godinho-Mota JCM, Martins KA, Vaz-Gonçalves L, Mota JF, Soares LR, Freitas-Junior R. Visceral adiposity increases the risk of breast cancer: a case-control study. Nutricion Hospitalaria. 2018;35(3):576–81.
- Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81–7. doi:https://doi.org/10.1097/MED.0b013e3283514e13
- Aparecida Silveira E, Vaseghi G, de Carvalho Santos AS, Kliemann N, Masoudkabir F, Noll M, Mohammadifard N, Sarrafzadegan N, de Oliveira C. Visceral obesity and its shared role in cancer and cardiovascular disease: a scoping review of the pathophysiology and pharmacological treatments. IJMS. 2020;21(23):9042. doi:https://doi.org/10.3390/ijms21239042
- Kang M, Lee A, Yoo HJ, Kim M, Kim M, Shin DY, Lee JH. Association between increased visceral fat area and alterations in plasma fatty acid profile in overweight subjects: a cross-sectional study. Lipids Health Dis. 2017;16(1):248. doi:https://doi.org/10.1186/s12944-017-0642-z
- Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutrit. 2007;86(3):867S–71S. doi:https://doi.org/10.1093/ajcn/86.3.867S
- Lee HA, Choi EJ, Park B, Lee H, Hong YS, Kim HS, Shin M-K, Park H. The association between metabolic components and markers of inflammatory and endothelial dysfunction in adolescents, based on the Ewha Birth and Growth Cohort Study. Plos One. 2020;15(5):e0233469. doi:https://doi.org/10.1371/journal.pone.0233469
- Kong D-H, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. IJMS. 2018;19(4):1057. doi:https://doi.org/10.3390/ijms19041057
- Teixeira GG, Mari NL, de Paula JCC, Cataldi de Alcantara C, Flauzino T, Lozovoy MAB, Martin LMM, Reiche EMV, Maes M, Dichi I, et al. Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis. Clin Exp Med. 2020;20(1):39–48. doi:https://doi.org/10.1007/s10238-019-00595-2
- Wang X, Liu Q, Wu L, Nie Z, Mei Z. Risk of non-melanoma skin cancer in patients with psoriasis: an updated evidence from systematic review with meta-analysis. J Cancer. 2020;11(5):1047–55. doi:https://doi.org/10.7150/jca.37015
- Kim T-K, Park CS, Na H-J, Lee K, Yoon A, Chung J, Lee S. Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis. Exp Mol Med. 2017;49(2):e294. doi:https://doi.org/10.1038/emm.2016.147
- Neyestani T. Immune alterations in metabolic syndrome: the old story of chicken and egg. In: Watson RR, Preedy VR, editors. Bioactive food as dietary interventions for arthritis and related inflammatory diseases: bioactive food in chronic disease states. Waltham, MA: Academic Press; 2012. p. 431–448.
- Francisco V, Ruiz-Fernández C, Pino J, Mera A, González-Gay MA, Gómez R, Lago F, Mobasheri A, Gualillo O. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196–206. doi:https://doi.org/10.1016/j.bcp.2019.03.030
- Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75. doi:https://doi.org/10.3945/an.115.010207
- González Maglio DH, Paz ML, Leoni J. Sunlight effects on immune system: is there something else in addition to UV-induced immunosuppression? Biomed Res Int. 2016;2016:1934518. doi:https://doi.org/10.1155/2016/1934518
- Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, Edlinger M, Häggström C, Engeland A, Johansen D, Kleiner A, et al. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).Br J Dermatol. 2012;167(1):59–67. doi:https://doi.org/10.1111/j.1365-2133.2012.10974.x
- Stefanadi EC, Dimitrakakis G, Antoniou C-K, Challoumas D, Punjabi N, Dimitrakaki IA, Punjabi S, Stefanadis CI. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. Diabetol Metab Syndr. 2018;10(1):9. doi:https://doi.org/10.1186/s13098-018-0311-z
- Uzunlulu M, Caklili OT, Oguz A. Association between metabolic syndrome and cancer. Ann Nutr Metab. 2016;68(3):173–9. doi:https://doi.org/10.1159/000443743